ReviewAdvances in therapy2022

P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease.

Robert A Hauser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.